Evonetix
Latest round
- Series B
Last raised
- Jan 2023
Total raised
- $66M
Investors
- 9
About Evonetix
Evonetix Ltd is a biotechnology company founded in 2015 and headquartered in Cambridge, UK. The company has developed a unique technology for gene synthesis, distinguishing itself in the synthetic biology field. Matthew Hayes founded Evonetix and has a history of innovation in the biotech sector.Evonetix specializes in a novel gene synthesis technology designed to transform the landscape of engineering biology. Their core offering is a groundbreaking platform that aims to deliver high-quality, gene-length DNA synthesis at unprecedented speed and scale, effectively bringing gene foundries to research laboratories worldwide. This technology addresses critical challenges related to the accessibility of accurate gene-length DNA, essential for advancements in healthcare, sustainable practices, and agricultural innovations. The company plans to expand its product offerings and enhance market penetration in North America, Europe, and Asia within the upcoming year.
Who invested in Evonetix
9 investors across 3 rounds
See all investors in Evonetix
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Evonetix
Who invested in Evonetix?
Evonetix has 9 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Evonetix raised?
Evonetix has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Evonetix last raise money?
Evonetix's most recent round on record is a Series B, in Jan 2023.
What does Evonetix do?
Evonetix Ltd is a biotechnology company founded in 2015 and headquartered in Cambridge, UK.
Where is Evonetix headquartered?
Evonetix is headquartered in Cambridge, UK.
Which VCs invest in companies like Evonetix?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Evonetix's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Evonetix? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.